Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
E Tuaillon, K Bolloré, A Pisoni, S Debiesse, C Renault, S Marie, S Groc, C Niels, N Pansu, AM Dupuy, D Morquin, V Foulongne, A Bourdin, V Le Moing, P Van de Perre
doi: https://doi.org/10.1101/2020.05.04.20090027
E Tuaillon
1Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France
K Bolloré
2Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, Montpellier, France
A Pisoni
1Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France
S Debiesse
2Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, Montpellier, France
C Renault
2Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, Montpellier, France
S Marie
3Montpellier University Hospital, Montpellier, France
S Groc
3Montpellier University Hospital, Montpellier, France
C Niels
3Montpellier University Hospital, Montpellier, France
N Pansu
3Montpellier University Hospital, Montpellier, France
AM Dupuy
3Montpellier University Hospital, Montpellier, France
D Morquin
3Montpellier University Hospital, Montpellier, France
V Foulongne
1Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France
A Bourdin
3Montpellier University Hospital, Montpellier, France
V Le Moing
3Montpellier University Hospital, Montpellier, France
P Van de Perre
1Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France
Data Availability
Not available
Posted May 27, 2020.
Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
E Tuaillon, K Bolloré, A Pisoni, S Debiesse, C Renault, S Marie, S Groc, C Niels, N Pansu, AM Dupuy, D Morquin, V Foulongne, A Bourdin, V Le Moing, P Van de Perre
medRxiv 2020.05.04.20090027; doi: https://doi.org/10.1101/2020.05.04.20090027
Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
E Tuaillon, K Bolloré, A Pisoni, S Debiesse, C Renault, S Marie, S Groc, C Niels, N Pansu, AM Dupuy, D Morquin, V Foulongne, A Bourdin, V Le Moing, P Van de Perre
medRxiv 2020.05.04.20090027; doi: https://doi.org/10.1101/2020.05.04.20090027
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (695)
- Anesthesia (186)
- Cardiovascular Medicine (2809)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12499)
- Forensic Medicine (10)
- Gastroenterology (796)
- Genetic and Genomic Medicine (4365)
- Geriatric Medicine (398)
- Health Economics (711)
- Health Informatics (2814)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (888)
- Medical Education (411)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4132)
- Nursing (219)
- Nutrition (613)
- Oncology (2178)
- Ophthalmology (616)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (260)
- Palliative Medicine (80)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (480)
- Public and Global Health (6721)
- Radiology and Imaging (1475)
- Respiratory Medicine (893)
- Rheumatology (427)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (197)
- Urology (173)